Evista
NDC 0002-4184, Raloxifene hydrochloride, tablet, from Eli Lilly and Company.
- Product NDC
- 0002-4184
- Status
- Listed
- Labeler
- Eli Lilly and Company
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA020815
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0002-4184 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RALOXIFENE HYDROCHLORIDE60 mg/1
Pharmacologic classes
Estrogen Agonist/Antagonist [EPC]; Selective Estrogen Receptor Modulators [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0002-4184-30 | 00002418430 | 30 TABLET in 1 BOTTLE (0002-4184-30) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/fcaaa6dc-74e8-4fb8-800c-5574bf0f8de9NADAC price for package 00002418430
GET /v1/drugs/nadac/00002418430
Use it
Look up 0002-4184 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0002-4184 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0002-4184. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.